Frontiers in Endocrinology · 2022 · 28 citations · 42 references
MedicineOncologyPathologyMetastasisNeoplasiaOncologic SurgeryCancer StagingCervical Lymph Node MetastasisLymph Node MetastasisLymphatic MetastasisMalignant NeoplasmsThyroid CancerAge StratificationClinical Nodal StagingDistant Nodal MetastasisLymph Node Metastasis PrognosisPapillary Thyroid Carcinoma PathologyRegional Lymph Node MetastasisStratificationThyroid Carcinoma Metastasis To Lymph Nodes
Background Distant metastasis (DM) is a rare event and has a negative effect on the prognosis for papillary thyroid carcinoma (PTC). The relationship between cervical lymph node metastasis and DM is complicated and unclear. This study aimed to evaluate the impact of N stage subclassification on different distant metastasis sites based on age stratification, especially for patients with papillary thyroid microcarcinoma. Methods A total of 28,712 patient with PTC cases between 2010 and 2018 were extracted from the Surveillance, Epidemiology, and End Results database. Multivariable logistic regression analysis was utilized to adjust for confounding variables. Risk stratification, including positive lymph node number and lymph node ratio, was established by receiver operating characteristic curves to help predict DM. Results Lung was the most common metastatic site regardless of N0, N1a disease, or N1b disease. As the N stage increased, the higher the rate of DM identified. After age stratification, only N1b disease significantly increased the risk of lung metastasis (LM; odds ratio, OR = 20.45, P < 0.001) rather than bone metastasis (BM; OR = 3.46, P > 0.05) in younger patients. However, in older patients, N1b disease significantly increased the risk of both LM (OR = 4.10, P < 0.001) and BM (OR = 2.65, P = 0.007). In patients with papillary thyroid microcarcinoma (PTMC), N1a disease did not increase the risk of DM, LM, and BM compared with N0 disease ( P > 0.05). Furthermore, combined N stage with risk stratification has well performance in predicting DM (area under the curve, AUC = 0.761). Similar results were shown in PTC patients with LM (AUC = 0.770) and BM (AUC = 0.729). Conclusion Overall, the incidence of DM significantly increased with the progress of N disease after age stratification. N1a disease did not increase the risk of DM in PTMC patients, regardless of LM or BM. Combined N stage with risk stratification may be beneficial for DM prediction.
42
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
Hyeyeun Lim, Susan S. Devesa, Julie Ann Sosa et al. · JAMA · 2017 · 2.2K citations · Full text
Medicine, Endocrinology, Oncology +17
Lymph Node Metastasis From 259 Papillary Thyroid Microcarcinomas
Nobuyuki Wada, Quan‐Yang Duh, Kiminori Sugino et al. · Annals of Surgery · 2003 · 827 citations · Full text
An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients
Yasuhiro Ito, Akira Miyauchi, Hiroyuki Inoue et al. · World Journal of Surgery · 2009 · 805 citations
Cancer incidence and mortality in China, 2015
Siwei Zhang, Kexin Sun, Rongshou Zheng et al. · Journal of the National Cancer Center · 2020 · 418 citations · Full text
Medicine, Health Sciences, Oncology +16